Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells. Saikosaponin B2 (5 μM) induces differentiation of B16 melanoma cells, with potentiation of expressions of tyrosinase and melanogenesis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 36.00 | |
5 mg | In stock | $ 79.00 | |
10 mg | In stock | $ 137.00 | |
25 mg | In stock | $ 252.00 | |
50 mg | In stock | $ 376.00 | |
100 mg | In stock | $ 565.00 | |
500 mg | In stock | $ 1,230.00 |
Description | Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells. Saikosaponin B2 (5 μM) induces differentiation of B16 melanoma cells, with potentiation of expressions of tyrosinase and melanogenesis. |
Source |
Molecular Weight | 780.98 |
Formula | C42H68O13 |
CAS No. | 58316-41-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 128 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Saikosaponin B2 58316-41-9 Microbiology/Virology Others Proteases/Proteasome HCV Protease HCV Saikosaponin B-2 Inhibitor Hepatitis C virus Saikosaponin B 2 inhibit inhibitor